LIVE TV
LIVE TV
LIVE TV
Home > World News > Strikes By US And Israel Hit Company Producing Cancer Drugs In Iran, Details Here

Strikes By US And Israel Hit Company Producing Cancer Drugs In Iran, Details Here

Joint US-Israel strikes hit Iran’s major pharma firm Tofigh Daru, damaging cancer drug production. Blasts were reported in Isfahan, including near the Natanz nuclear facility, raising concerns over medicine shortages and escalating conflict.

Published By: Aditya Wadhawan
Last updated: April 2, 2026 12:28:02 IST

Add NewsX As A Trusted Source

Joint strikes by US and Israel has targeted the largest pharmaceutical company in Iran which produces anesthetic and cancer drugs. “During the US and Zionist regime attacks on civilian centers, on the morning of Tuesday, one of the largest companies producing anti-cancer, anaesthetic and specialised medicines was damaged, and the drug production line was damaged,” Iranian government said in a post on X.

The pharmaceutical company is owned by the Social Security Investment Company, a state-run holding firm managing pension fund.  

“Tofigh Daru, Research and Engineering Company was targeted by desperate aggressors who failed to realize their diabolical delusions and deliberately struck a medical production facility,” said Javad Zarif, Iran’s former foreign minister and founder of the Payab Research Institute. 

Heavy bombing was also reported in Isfahan, which is a key hub for Iran’s defence industry and has major nuclear facilities, including Natanz. Iran has for long faced chronic shortages of medicines, partly due to UN sanctions imposed over its nuclear programme. 

Iranian state media also reported that a Shia religious site in the country’s northwest suffered damage in the strikes.

RELATED News

LATEST NEWS